Biography of Mark Shearman
Last update: March 2, 2024Career
Mark was Chief Scientific Officer and Executive Vice President at Editas Medicine, and Chief Scientific Officer at Beacon Therapeutics. Mark served as Advisory Board Chair at Aprinoia Therapeutics.
Mark Shearman is currently Chief Executive Officer at Aprinoia Therapeutics - View - Aprinoia Therapeutics org chart
Create your alert
to follow the career of Mark Shearman.
Education
Mark Shearman has a PhD in Brain Monoamine Receptor Signallingd from University of Nottingham.
They have also studied at University of Nottingham :
Find more alumni from University of Nottingham
More about Mark Shearman
Selected links
Do you need to know more about Mark Shearman? More results.
Participate
Social media
- Mark Shearman on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Mark Shearman
The colleagues of Mark Shearman
Company Colleagues
- At Aprinoia Therapeutics, Mark Shearman has 8 colleagues including Ming-Kuei Jang (Chairman of the Board), Lili Zhang (Preclinical Development)…
Industry Colleagues
- In the Biotechnology industry, Mark Shearman has 30,477 colleagues in 2,294 companies located in 39 countries. 14,198 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mark Shearman.
